Skip to main content
Clinical Trials/ACTRN12612000795897
ACTRN12612000795897
Completed
Phase 4

A randomized controlled trial comparing the effectiveness of intranasal ketamine and fentanyl in the relief of moderate to severe pain in children with limb injuries.

Southern Health0 sites80 target enrollmentJuly 27, 2012

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
analgesic effectiveness
Sponsor
Southern Health
Enrollment
80
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 27, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Southern Health

Eligibility Criteria

Inclusion Criteria

  • Children aged three to 13 years and under 50kg body weight
  • Musculoskeletal injury to upper and/or lower limbs
  • Visual analogue pain score greater than or equal to 6/10 on the standard 11\-point verbal rating scale (0 \= none, 10 \= worst pain imaginable) and patient would normally be considered for intranasal fentanyl administration.
  • Use of simple analgesia such as paracetamol or ibuprofen or inhalational methoxyflurane during ambulance transport are not exclusion criteria

Exclusion Criteria

  • Inability to gain informed consent from parent or guardian
  • Prior administration of parenteral or intranasal analgesics (morphine, fentanyl)
  • Prior administration of oral opioid analgesia (oxycodone, codeine)
  • Allergy to ketamine, fentanyl, or ibuprofen
  • Aberrant nasal anatomy
  • Acute or chronic nasal problems or nasal trauma that may preclude adequate administration or absorption of intranasal medication.
  • Presence of multiple trauma or injuries.
  • Sustained a head injury with loss of consciousness.
  • Presence of cognitive impairment.

Outcomes

Primary Outcomes

Not specified

Similar Trials